These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 11685824)
1. Free fatty acids--do they play a central role in type 2 diabetes? Arner P Diabetes Obes Metab; 2001 Aug; 3 Suppl 1():S11-9. PubMed ID: 11685824 [No Abstract] [Full Text] [Related]
2. [PPAR gamma: a major nuclear receptor in adipogenesis]. Gervois P; Fruchart JC Med Sci (Paris); 2003 Jan; 19(1):20-2. PubMed ID: 12836187 [No Abstract] [Full Text] [Related]
3. Insulin resistance and obesity. Schwartz MW; Kahn SE Nature; 1999 Dec 23-30; 402(6764):860-1. PubMed ID: 10622250 [No Abstract] [Full Text] [Related]
4. Effects of free fatty acids (FFA) on glucose metabolism: significance for insulin resistance and type 2 diabetes. Boden G Exp Clin Endocrinol Diabetes; 2003 May; 111(3):121-4. PubMed ID: 12784183 [TBL] [Abstract][Full Text] [Related]
5. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. Bays H; Mandarino L; DeFronzo RA J Clin Endocrinol Metab; 2004 Feb; 89(2):463-78. PubMed ID: 14764748 [No Abstract] [Full Text] [Related]
6. [Free fatty acids: mediators of insulin resistance and atherosclerosis]. Castro Cabezas M; Erkelens DW; van Dijk H Ned Tijdschr Geneeskd; 2002 Jan; 146(3):103-9. PubMed ID: 11826668 [TBL] [Abstract][Full Text] [Related]
7. Metabolic fluxes in skeletal muscle in relation to obesity and insulin resistance. Blaak EE Best Pract Res Clin Endocrinol Metab; 2005 Sep; 19(3):391-403. PubMed ID: 16150382 [TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of lipid-induced insulin resistance in muscle, liver and vasculature. Krebs M; Roden M Diabetes Obes Metab; 2005 Nov; 7(6):621-32. PubMed ID: 16219006 [TBL] [Abstract][Full Text] [Related]
9. Basic disturbances in skeletal muscle fatty acid metabolism in obesity and type 2 diabetes mellitus. Blaak EE Proc Nutr Soc; 2004 May; 63(2):323-30. PubMed ID: 15294050 [TBL] [Abstract][Full Text] [Related]
11. Fatty acids and insulin resistance in muscle and liver. Kovacs P; Stumvoll M Best Pract Res Clin Endocrinol Metab; 2005 Dec; 19(4):625-35. PubMed ID: 16311221 [TBL] [Abstract][Full Text] [Related]
12. [Antidiabetic effect of thiazolidinediones]. Girard J Journ Annu Diabetol Hotel Dieu; 2001; ():33-45. PubMed ID: 11565467 [No Abstract] [Full Text] [Related]
13. Fatty acid metabolism in obesity and type 2 diabetes mellitus. Blaak EE Proc Nutr Soc; 2003 Aug; 62(3):753-60. PubMed ID: 14692611 [TBL] [Abstract][Full Text] [Related]
14. PPARs and the complex journey to obesity. Evans RM; Barish GD; Wang YX Nat Med; 2004 Apr; 10(4):355-61. PubMed ID: 15057233 [TBL] [Abstract][Full Text] [Related]
15. Direct and macrophage-mediated actions of fatty acids causing insulin resistance in muscle cells. Bilan PJ; Samokhvalov V; Koshkina A; Schertzer JD; Samaan MC; Klip A Arch Physiol Biochem; 2009 Oct; 115(4):176-90. PubMed ID: 19671019 [TBL] [Abstract][Full Text] [Related]
16. The road from obesity to type 2 diabetes. Ioannidis I Angiology; 2008; 59(2 Suppl):39S-43S. PubMed ID: 18505743 [TBL] [Abstract][Full Text] [Related]
17. [Peroxisome proliferator activated receptors PPARs: their role in carbohydrate and lipid metabolism]. Andrééva-Gatéva P Ann Biol Clin (Paris); 2003; 61(3):295-303. PubMed ID: 12805006 [TBL] [Abstract][Full Text] [Related]
19. Skeletal muscle and nuclear hormone receptors: implications for cardiovascular and metabolic disease. Smith AG; Muscat GE Int J Biochem Cell Biol; 2005 Oct; 37(10):2047-63. PubMed ID: 15922648 [TBL] [Abstract][Full Text] [Related]
20. Focus issue: the signaling skinny on obesity. Chong LD; Adler EM; Ray LB Sci STKE; 2003 Feb; 2003(169):EG2. PubMed ID: 12582198 [No Abstract] [Full Text] [Related] [Next] [New Search]